Yes, Slug can serve as a potential biomarker for both prognosis and therapeutic response. Elevated levels of Slug in tumor tissues can indicate aggressive disease and a higher likelihood of metastasis. Monitoring Slug expression can help in predicting patient outcomes and tailoring personalized treatment strategies.
